FDA Adverse Event Malfunction Summary report: N

TOSOH HLC-723G8 ANALYZER G8

MDR report key: 7340041 · Received March 14, 2018

Report

Report Number
8031673-2018-02714
Event Type
Malfunction
Date Received
March 14, 2018
Date of Event
January 28, 2016
Report Date
March 14, 2018
Manufacturer
TOSOH CORPORATION
Product Code
LCP
PMA / PMN Number
K071132
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AL, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

TOSOH BIOSCIENCE, INC. IS SUBMITTING ON BEHALF OF THE FOREIGN MANUFACTURER, TOSOH CORPORATION, PER EXEMPTION NUMBER E2017013. THIS REPORT IS BEING SUBMITTED DUE TO A RETROSPECTIVE REVIEW CONDUCTED UNDER CAPA (B)(4). ON 29-JAN-2016, FSE ARRIVED AT THE SITE TO ADDRESS THE REPORTED EVENT. INSPECTION/ TESTING OF THE DEVICE FOUND THAT PATIENT RESULTS WERE RETURNING WITH "HEMOGLOBIN VARIANT (HB-VAR) DETECT" ERRORS. FSE RAN SEVERAL SAMPLES, PRIMED THE DEVICE, AND ENABLED "OPTION M". HE ALSO INTERFACED THE ANALYZER TO THE LABORATORY INFORMATION SYSTEM (LIS) AND RETESTED. THE CUSTOMER WAS SUBSEQUENTLY, ABLE TO CALIBRATE AND RUN QUALITY CONTROL (QC) WITHOUT ISSUE. NO FURTHER ACTION WAS REQUIRED BY FIELD SERVICE. OF NOTE, THE DEVICE HAD NOT BEEN IN USE FOR TWENTY-FIVE DAYS PRIOR TO THE REPORTED EVENT. THE MOST PROBABLE CAUSE OF THE REPORTED EVENT WAS DUE TO COMMUNICATION ISSUES WITH INSTRUMENT INTERFACE SETTINGS.

Description of Event or Problem · 0

ON (B)(6) 2016, THE CUSTOMER REPORTED CALIBRATION ERRORS AND LOW TOTAL AREAS ON PATIENT SAMPLES WITH THEIR G8 ANALYZER. THE CUSTOMER STATED THAT THERE WERE NO OBVIOUS LEAKS AND THE DEVICE PRESSURES WERE NORMAL. ON (B)(6) 2016, A FIELD SERVICE ENGINEER (FSE) WAS DISPATCHED TO ADDRESS THE REPORTED EVENT, WHICH RESULTED IN DELAYED REPORTING HBA1C PATIENT RESULTS. THERE WAS NO INDICATION OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THE DELAY IN REPORTING.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
181718 TOSOH HLC-723G8 ANALYZER G8 G8 LCP TOSOH CORPORATION G8

Patients

Seq Age Sex Outcome Treatment
1